BioSpace News Archive

Blueprint Medicines Corporation announced that, effective on April 1, 2021, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 27,543 shares of its common stock and an aggregate of 13,792 restricted stock units to 14 new employees under Blueprint Medicines’ 2020 Inducement Plan.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian , Ph.D., will deliver a corporate presentation as part of the 20 th Annual Needham Virtual Healthcare Conference

Presenters include Dr. Amir Azadi of Barrow Neurological Institute, Dr. Nicholas Blondin of Yale University and Dr. Priya U. Kumthekar of Northwestern University W ebinar begins tomorrow, April 8, at 12:00 p.m. Eastern Time

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that it has commenced an underwritten public offering of its common stock.

PhaseBio Pharmaceuticals to Present at 20 th Annual Needham Virtual Healthcare Conference

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its first quarter 2021, financial results on Wednesday, May 5, 2021.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:45 a.m. Eastern Time.

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17th. Management will host a conference call at 5:00 p.m. Eastern Time on May 17th to discuss the results of the quarter and fiscal year.

Kaiser Permanente announced today that Diane Comer has been named the organization’s new chief information technology officer.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis have voluntarily agreed to step down from the Board of Directors of Tenax Therapeutic